CCH NetNews™

(October 20, 2009)

Food and Drug Law

Order or Get More Information in the CCH®s Online Store

 New and Improved

Continuing to to provide you with the most up-to-date, accurate information, CCH introduces new enhancements for the Food, Drug & Cosmetic Reporter and the Medical Devices Reporter. These include:

  • New food safety & security explanations, incorporating Bioterrorism Act provisions
  • Significant additions to the Hatch-Waxman explanations on generic drug approvals
  • New coverage of combination drug, biologics, and device products
  • More detailed explanations on drug, vet drug, and device user fees
  • Updated, comprehensive coverage of over-the-counter drug monographs
  • Additional reporting on food and drug good manufacturing practices

The Food, Drug & Cosmetic Reporter provides everything you need to know about Food and Drug Regulations. Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics.

Order Your Subscription Today »

The Medical Devices Reporter provides access to the full text plus expert analysis of all laws and regulations governing the classification, approval, manufacture, and marketing of all medical diagnostic, and radiological devices.

Order Your Subscription Today »

 

Want to receive these Newsletters via E-mail?

Sign Up / Unsubscribe

CCH Health Care Resources
About the Links in This Newsletter:

To access the CCH® Internet Research Network™ (IRN) full text documents you must be a subscriber to the Medical Devices Reporter or Food, Drug and Cosmetic Law Reporter, IRN product (depending on the link).*

Links within news stories display full text documents including legislation, regulations, court decisions, rulings and government reports.

The first time you click on a link you will be taken to the IRN login page, where you will need to enter your ID and password. Subsequent links will take you directly to the desired document.

Want to Subscribe?

If you aren’t a subscriber call 800-449-9525 or let us contact you about the Medicare and Medicaid Guide.

Signing up for a 7 day free trial will allow you to click on the links within the news stories and see the full text documents.

E-Mail Us

Featured This Week:

Fospropofol placed as Schedule IV substance

The Drug Enforcement Administration (DEA) placed the substance fospropofol, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act. Fospropofol was approved by the FDA under the trade name Lusedra® for use as a drug product indicated for monitored anesthesia care sedation in adult patients undergoing diagnostic or therapeutic procedures. Fospropofol acts as a central nervous system depressant and elicits behavioral effects similar to Schedule IV sedative-hypnotics. The effective date of the final rule is November 5, 2009. DEA Order.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Dried sugar cane syrup labeling clarified

Dried sweeteners derived from sugar cane syrup for use in food products should not be declared on labels as “evaporated cane juice,” in a draft guidance published by the FDA. Titled Guidance for Industry: Ingredients Declared as Evaporated Cane Juice,the draft document recommends to manufacturers that the phrase evaporated cane juice” not be used because it is not the common or usual name of the cane syrup sweeteners. The sweetener, instead, should be labeled as “dried cane syrup,”The inappropriate usage of “juice” on labels for dried syrup would result in misbranded or adulterated products. FDA Notice.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

USDA joins food safety efforts

On October 5, 2009, the FDA announced that the U.S. Department of Agriculture's (USDA) fresh produce chief Leanne Skelton will join the FDA to help develop new food safety rules, as part of a cooperative initiative between FDA and the USDA. Skelton has extensive experience working with the fruit and vegetable industry and will be on detail with the FDA for six months to help the agency develop new safety regulations for produce. Through the initiative, the FDA is gathering information and seeking feedback from the fresh produce industry, including small and organic farmers, on the impact such rules may have on their businesses and lives. FDA News Release.

$17.5 million in food and feed safety grants awarded

On October 9, 2009, the FDA announced that it awarded 83 grants in fiscal year (FY) 2009 totaling $17.5 million to state and local regulatory agencies to boost food and feed safety initiatives. The grants fund major cooperative agreements in the four major areas of response, intervention, innovation, and prevention. The FDA's Food Protection Rapid Response Team (RRT) and Program Infrastructure Improvement Prototype Project cooperative agreements will develop, implement, exercise, and integrate an all-hazards food and foodborne illness response capability to more rapidly react to potential threats to the U.S. food supply. The Food Protection Task Force Conference program supports meetings that foster communication, cooperation, and collaboration among state, local, and tribal food protection, public health, agriculture, and regulatory agencies. FDA News Release.

CCH is the leading provider of information covering Medicare & Medicaid, Healthcare Compliance, Food, Drug & Cosmetic Law, and Home Health. For more information about our products and services, go to http://health.cch.com/ or call 800-449-9525. This newsletter is copyrighted by CCH and may be redistributed only for non-commercial purposes and only in its entirety, specifically including the CCH headers, this paragraph and the CCH copyright line. No other redistribution or re-purposing, including but not limited to use on a web site, intranet or extranet, is permitted without prior written permission of CCH.

© 2009 CCH. All Rights Reserved.

To opt out of this newsletter or to make changes to your email preferences click here.

contactus@wolterskluwerlb.com